Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Min Li PhD"'
Publikováno v:
Technology in Cancer Research & Treatment, Vol 23 (2024)
Proton radiotherapy may be a compelling technical option for the treatment of breast cancer due to its unique physical property known as the “Bragg peak.” This feature offers distinct advantages, promising superior dose conformity within the tumo
Externí odkaz:
https://doaj.org/article/912ceb297fc64c17978d3378e0bd05da
Autor:
Jun Cai PhD, Xing-Xing Fan PhD, Run-Ze Li PhD, Hong Lin PhD, Min Li PhD, Qi Song PhD, Chun Xie MS, Gregory Wong PhD, Sam Ting-Chung Liu PhD, Ya-Bing Cao PhD, Elaine Lai-Han Leung PhD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 22 (2023)
Objectives: Despite the development of various cancer treatment methods, chemotherapy remains the most common approach for treating cancer. The risk of tumors acquiring resistance to chemotherapy remains a significant hurdle to the successful treatme
Externí odkaz:
https://doaj.org/article/d5d95f761e3a42cf91bd5f45a1e7f2bb
Autor:
Min Li, PhD, Lianhui Zhao, MD, Jialing Zhou, MSc, Yameng Sun, MD, Xiaoning Wu, MD, Xiaojuan Ou, MD, Hong You, MD, Yuanyuan Kong, PhD, Jidong Jia, MD
Publikováno v:
The Lancet Regional Health. Western Pacific, Vol 16, Iss , Pp 100249- (2021)
Background: High uptake of hepatitis B virus (HBV) tests and antiviral therapy are required to improve the clinical outcomes of patients with chronic hepatitis B (CHB) at the population level. In the current study, we used the Basic Medical Care Insu
Externí odkaz:
https://doaj.org/article/474df036d3d74390bd24256338bd6a8f
Autor:
Yuzhi Yin, MD, PhD, Jenny Min Li, PhD, Dean D. Metcalfe, MD, Ana Olivera, PhD, Pamela A. Frischmeyer-Guerrerio, MD, PhD, Melody C. Carter, MD, Hirsh Komarow, MD
Publikováno v:
Journal of Allergy and Clinical Immunology: Global, Vol 3, Iss 4, Pp 100296- (2024)
Background: Symptoms in patients with systemic mastocytosis (SM) are associated with an increase in mast cell burden and release of mast cell–derived mediators. The most frequent presentation of SM is indolent SM (ISM), with moderate symptoms and p
Externí odkaz:
https://doaj.org/article/7ae7eb01fa14400089442bdc7c6a81fe
Publikováno v:
Technology in Cancer Research & Treatment, Vol 20 (2021)
Background: The overall prognosis of lung cancer remains unfavorable and novel prognostic biomarkers of lung cancer are needed warranted. Accumulating evidence indicate that systemic inflammation plays a vital role in lung cancer. The lymphocyte-to-m
Externí odkaz:
https://doaj.org/article/9cd67334eee64787aefc09ecefd3c592